Medicinal use of galiella lactone as specific interleukin-6 signal induction inhibitor e.g. in treatment of fibrotic, cerebrovascular or neurodegenerative disease, pain, inflammation or tumors
Galiella lactone (I) (a fused tricyclic hydroxy-lactone) is claimed for the prophylaxis and/or treatment of diseases. Galiella lactone of formula (I) and specifically having given H-NMR, C-NMR and IR spectral characteristics, is claimed for the prophylaxis and/or treatment of diseases. Independent c...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WEIDLER, MARCUS ANKE, HEIDRUN ERKEL, GERHARD BAUMGARTEN, JOERG ANKE, TIMM |
| description | Galiella lactone (I) (a fused tricyclic hydroxy-lactone) is claimed for the prophylaxis and/or treatment of diseases. Galiella lactone of formula (I) and specifically having given H-NMR, C-NMR and IR spectral characteristics, is claimed for the prophylaxis and/or treatment of diseases. Independent claims are included for the use of (I) for the preparation of medicaments for the prophylaxis and/or treatment of diseases and medicaments containing (I) and pharmaceutical auxiliaries.
Die Erfindung betrifft die Verwendung der unter dem Namen Galiella-Lacton bekannten Substanz als Arzneimittel, insbesondere zur Behandlung von entzündlichen Prozessen. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DE10047295A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DE10047295A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DE10047295A13</originalsourceid><addsrcrecordid>eNqNjTFOA0EMRbehQMAdTL-JEghElAiCaOjoI2f2z2Jl1rMae3I-jsYEcQAq_y_993zZfX9gkCDKiaqBcqSRkyAlpsTBs4LYyGYEiRJI1FES6lF08Ugm4xkUHWpwydrSlxzEcyEsx2Wr5AXsE9TP6iiHkl1CTwEFLZ_YQk1cqBGKWvKAEYrCLifQIAY29DSzaN9sMfE08e-nBnidcrHr7iJyMtz83avu9m33-fK-wJz3sJlDE_r-dbderTbbu6eH5_X9fzY_lv1hQg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Medicinal use of galiella lactone as specific interleukin-6 signal induction inhibitor e.g. in treatment of fibrotic, cerebrovascular or neurodegenerative disease, pain, inflammation or tumors</title><source>esp@cenet</source><creator>WEIDLER, MARCUS ; ANKE, HEIDRUN ; ERKEL, GERHARD ; BAUMGARTEN, JOERG ; ANKE, TIMM</creator><creatorcontrib>WEIDLER, MARCUS ; ANKE, HEIDRUN ; ERKEL, GERHARD ; BAUMGARTEN, JOERG ; ANKE, TIMM</creatorcontrib><description>Galiella lactone (I) (a fused tricyclic hydroxy-lactone) is claimed for the prophylaxis and/or treatment of diseases. Galiella lactone of formula (I) and specifically having given H-NMR, C-NMR and IR spectral characteristics, is claimed for the prophylaxis and/or treatment of diseases. Independent claims are included for the use of (I) for the preparation of medicaments for the prophylaxis and/or treatment of diseases and medicaments containing (I) and pharmaceutical auxiliaries.
Die Erfindung betrifft die Verwendung der unter dem Namen Galiella-Lacton bekannten Substanz als Arzneimittel, insbesondere zur Behandlung von entzündlichen Prozessen.</description><edition>7</edition><language>eng ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2002</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020411&DB=EPODOC&CC=DE&NR=10047295A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20020411&DB=EPODOC&CC=DE&NR=10047295A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WEIDLER, MARCUS</creatorcontrib><creatorcontrib>ANKE, HEIDRUN</creatorcontrib><creatorcontrib>ERKEL, GERHARD</creatorcontrib><creatorcontrib>BAUMGARTEN, JOERG</creatorcontrib><creatorcontrib>ANKE, TIMM</creatorcontrib><title>Medicinal use of galiella lactone as specific interleukin-6 signal induction inhibitor e.g. in treatment of fibrotic, cerebrovascular or neurodegenerative disease, pain, inflammation or tumors</title><description>Galiella lactone (I) (a fused tricyclic hydroxy-lactone) is claimed for the prophylaxis and/or treatment of diseases. Galiella lactone of formula (I) and specifically having given H-NMR, C-NMR and IR spectral characteristics, is claimed for the prophylaxis and/or treatment of diseases. Independent claims are included for the use of (I) for the preparation of medicaments for the prophylaxis and/or treatment of diseases and medicaments containing (I) and pharmaceutical auxiliaries.
Die Erfindung betrifft die Verwendung der unter dem Namen Galiella-Lacton bekannten Substanz als Arzneimittel, insbesondere zur Behandlung von entzündlichen Prozessen.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2002</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjTFOA0EMRbehQMAdTL-JEghElAiCaOjoI2f2z2Jl1rMae3I-jsYEcQAq_y_993zZfX9gkCDKiaqBcqSRkyAlpsTBs4LYyGYEiRJI1FES6lF08Ugm4xkUHWpwydrSlxzEcyEsx2Wr5AXsE9TP6iiHkl1CTwEFLZ_YQk1cqBGKWvKAEYrCLifQIAY29DSzaN9sMfE08e-nBnidcrHr7iJyMtz83avu9m33-fK-wJz3sJlDE_r-dbderTbbu6eH5_X9fzY_lv1hQg</recordid><startdate>20020411</startdate><enddate>20020411</enddate><creator>WEIDLER, MARCUS</creator><creator>ANKE, HEIDRUN</creator><creator>ERKEL, GERHARD</creator><creator>BAUMGARTEN, JOERG</creator><creator>ANKE, TIMM</creator><scope>EVB</scope></search><sort><creationdate>20020411</creationdate><title>Medicinal use of galiella lactone as specific interleukin-6 signal induction inhibitor e.g. in treatment of fibrotic, cerebrovascular or neurodegenerative disease, pain, inflammation or tumors</title><author>WEIDLER, MARCUS ; ANKE, HEIDRUN ; ERKEL, GERHARD ; BAUMGARTEN, JOERG ; ANKE, TIMM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DE10047295A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; ger</language><creationdate>2002</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>WEIDLER, MARCUS</creatorcontrib><creatorcontrib>ANKE, HEIDRUN</creatorcontrib><creatorcontrib>ERKEL, GERHARD</creatorcontrib><creatorcontrib>BAUMGARTEN, JOERG</creatorcontrib><creatorcontrib>ANKE, TIMM</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WEIDLER, MARCUS</au><au>ANKE, HEIDRUN</au><au>ERKEL, GERHARD</au><au>BAUMGARTEN, JOERG</au><au>ANKE, TIMM</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Medicinal use of galiella lactone as specific interleukin-6 signal induction inhibitor e.g. in treatment of fibrotic, cerebrovascular or neurodegenerative disease, pain, inflammation or tumors</title><date>2002-04-11</date><risdate>2002</risdate><abstract>Galiella lactone (I) (a fused tricyclic hydroxy-lactone) is claimed for the prophylaxis and/or treatment of diseases. Galiella lactone of formula (I) and specifically having given H-NMR, C-NMR and IR spectral characteristics, is claimed for the prophylaxis and/or treatment of diseases. Independent claims are included for the use of (I) for the preparation of medicaments for the prophylaxis and/or treatment of diseases and medicaments containing (I) and pharmaceutical auxiliaries.
Die Erfindung betrifft die Verwendung der unter dem Namen Galiella-Lacton bekannten Substanz als Arzneimittel, insbesondere zur Behandlung von entzündlichen Prozessen.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; ger |
| recordid | cdi_epo_espacenet_DE10047295A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Medicinal use of galiella lactone as specific interleukin-6 signal induction inhibitor e.g. in treatment of fibrotic, cerebrovascular or neurodegenerative disease, pain, inflammation or tumors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T12%3A28%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WEIDLER,%20MARCUS&rft.date=2002-04-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDE10047295A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |